Small chloroquine study halted over risk of fatal heart complications - Chicago Tribune
They upped the dose by a third, and 11 people died.
They upped the dose by a third, and 11 people died.
Roughly half the study participants were given a dose of 450 milligrams of chloroquine twice daily for five days, while the rest were prescribed a higher dose of 600 milligrams for 10 days. Within three days, researchers started noticing heart arrhythmias in patients taking the higher dose.
By the sixth day of treatment, 11 patients had died, leading to an immediate end to the high-dose segment of the trial.
Last edited: